Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from PharmaTher Holdings Ltd ( (TSE:PHRM) ) is now available.
PharmaTher Holdings Ltd is a specialty pharmaceutical company focused on unlocking the therapeutic potential of psychedelics and peptides. It develops its proprietary PharmaPatch microneedle patch platform to deliver drugs in a needle-free, at-home format aimed at improving convenience, adherence, and differentiated pharmacokinetic profiles in the U.S. market.
PharmaTher announced a strategic initiative to expand its PharmaPatch platform into select therapeutic peptides for the U.S. market, building on its ketamine, psychedelic and GLP-1 patch programs. The company is initially evaluating peptides such as BPC-157, GHK-Cu, TB-500, KPV and combinations, positioning itself to capture part of a U.S. peptide therapeutics market projected to grow from about US$65.1 billion in 2024 to roughly US$160.3 billion by 2030.
The company argues that a peptide microneedle patch could address real-world challenges of injection-based regimens by enabling painless, at-home, sustained delivery that may improve adherence in chronic conditions. PharmaTher’s plans include staged feasibility work, potential clinical evaluation, manufacturing scale-up, and intellectual property filings, supported by prior microneedle R&D proof points in ketamine and multiple psychedelics.
The most recent analyst rating on (TSE:PHRM) stock is a Sell with a C$0.07 price target. To see the full list of analyst forecasts on PharmaTher Holdings Ltd stock, see the TSE:PHRM Stock Forecast page.
Spark’s Take on TSE:PHRM Stock
According to Spark, TipRanks’ AI Analyst, TSE:PHRM is a Neutral.
The score is primarily held down by weak financial performance (pre-revenue, ongoing losses, negative cash flow, and shrinking equity) and poor technicals (price below key moving averages with negative MACD). Improved loss/cash-burn trends and zero reported debt provide partial offset, while valuation is hard to assess meaningfully due to negative earnings and no dividend data.
To see Spark’s full report on TSE:PHRM stock, click here.
More about PharmaTher Holdings Ltd
PharmaTher Holdings Ltd is a specialty pharmaceutical company focused on unlocking the therapeutic potential of psychedelics and peptides. The company develops needle-free microneedle patch technologies under its PharmaPatch platform, targeting more convenient, patient-friendly drug delivery solutions in the U.S. market, particularly for chronic and emerging therapeutic areas.
Average Trading Volume: 66,210
Technical Sentiment Signal: Sell
Current Market Cap: C$6.83M
For an in-depth examination of PHRM stock, go to TipRanks’ Overview page.